Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Intramuscular (IM) hydroxocobalamin is the recommended first-line treatment for pernicious anaemia in the UK, as advised by NICE and the British Society for Haematology
Preclinical Safety Evaluation In preclinical studies, BPC 157 did not lead to any serious toxicity in tested animals, including: mice rats rabbits dogs These studies provide a strong foundation for understanding the safety profile of BPC 157, indicating that it is well-tolerated across different species
The injections work by correcting deficiency, not by super-charging normal physiology
This BPC-157 10MG product page is intended to provide educational, research-only information focused on compound classification, scientific context, and non-clinical investigation
Purchasers must be 21+ and qualified to handle research materials.
.jpg)
US$ 26.82
US$ 29.14
US$ 28.50
US$ 28.20
US$ 27.38
US$ 26.41
US$ 22.65
US$ 22.58
